Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
QuintilesIMS
Argus Health
Teva
UBS
Colorcon
Queensland Health
Cantor Fitzgerald
Merck
Accenture

Generated: August 21, 2017

DrugPatentWatch Database Preview

SPIRONOLACTONE Drug Profile

« Back to Dashboard

What is the patent landscape for Spironolactone, and what generic Spironolactone alternatives are available?

Spironolactone is a drug marketed by Ivax Pharms, Sandoz, Accord Hlthcare, Mylan, Sun Pharm Inds, Amneal Pharms, Lederle, Vangard, Vintage, Warner Chilcott, Actavis Elizabeth, Jubilant Generics, Purepac Pharm, Upsher Smith, Superpharm, Mutual Pharm, Watson Labs, Ascot, Orion Corp Orion, Parke Davis, and Usl Pharma. and is included in thirty-nine NDAs.

The generic ingredient in SPIRONOLACTONE is hydrochlorothiazide; spironolactone. There are thirty-one drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; spironolactone profile page.

Summary for Tradename: SPIRONOLACTONE

Patents:0
Applicants:21
NDAs:39
Suppliers / Packagers: see list38
Bulk Api Vendors: see list45
Clinical Trials: see list159
Patent Applications: see list6,095
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SPIRONOLACTONE at DailyMed

Pharmacology for Tradename: SPIRONOLACTONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; spironolactone
TABLET;ORAL089534-001Jul 2, 1987ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
SPIRONOLACTONE
spironolactone
TABLET;ORAL087086-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
hydrochlorothiazide; spironolactone
TABLET;ORAL086026-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; spironolactone
TABLET;ORAL087398-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE
hydrochlorothiazide; spironolactone
TABLET;ORAL087948-001Feb 22, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Julphar
Moodys
Daiichi Sankyo
US Department of Justice
McKinsey
Merck
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot